The RIQAS CO-Oximetry EQA programme is a comprehensive programme suitable for monitoring the performance of 7 CO-Oximetry parameters. All samples are supplied in a liquid ready-to-use format ideal for both clinical and point-of-care testing (POCT).
- Liquid ready-to-use
- Monthly reporting
- Submit results and view reports online via RIQAS.Net
- Suitable for POCT
Not accredited to ISO/IEC 17043
|Cat No||Kit Size||Frequency||Cycle Start||Parameters|
|*For the first registered instrument **For all subsequent instruments|
|RQ9177 *||1.2 ml||Monthly||April||7|
|RQ9177/A **||1.2 ml||Monthly||April||7|
Note to participants with multiple instruments on the CO-Oximetry Programme:
RQ9177 must be purchased for the first registered instrument and individual RQ9177/A kits purchased for each subsequently registered instrument.
- Carboxyhaemoglobin (COHb / HbCO)
- Methaemoglobin (MetHb)
- Oxygen Content (O₂CT)
- Oxygen Saturation (sO₂ / Vol O₂)
- Oxyhaemoglobin (O₂Hb / HbO₂)
- Total Haemoglobin (tHb)
- Reduced / Deoxyhaemoglobin (RHb / HHb)
About CO-Oximetry EQA
Co-oximetry is a methodology, also known as spectrophotometry, that measures the levels of the oxygen-carrying protein haemoglobin, which is the chief component of red blood cells. Co-oximetry is a useful tool in that it helps determine the levels of various forms of haemoglobin.
Spectrophotometric methods date back to studies by Sir Isaac Newton in the 1600s. Work by Lambert (1760) and Beer (1852) resulted in the Beer-Lambert law which describes the transmission / absorption of light in solutions (Chatburn, 2014).
A high value for the Co-Oximetry Blood Test may indicate, among other things:
- Carbon monoxide poisoning
- Congenital haemoglobin disorder